My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 299

    1.

    Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.

    Knowles NG, Landchild MA, Fujimoto WY, Kahn SE.

    Diabetes Care. 2002 Feb;25(2):292-7.PMID: 11815498 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Increased secretion of 32,33 split proinsulin after intravenous glucose in glucose-tolerant first-degree relatives of patients with non-insulin dependent diabetes of European, but not Asian, origin.

    Gelding SV, Andres C, Niththyananthan R, Gray IP, Mather H, Johnston DG.

    Clin Endocrinol (Oxf). 1995 Mar;42(3):255-64.PMID: 7758230 [PubMed - indexed for MEDLINE]Related articles

    3.

    Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

    Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY.

    Diabetes. 1998 Apr;47(4):640-5.PMID: 9568698 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

    Henriksen JE, Alford F, Ward GM, Beck-Nielsen H.

    Diabetologia. 1997 Dec;40(12):1439-48.PMID: 9447952 [PubMed - indexed for MEDLINE]Related articles

    5.

    Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

    Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group.

    Diabetes. 2002 Jul;51(7):2170-8.PMID: 12086947 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

    Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

    Diabetes Care. 2006 May;29(5):1031-8.PMID: 16644633 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.

    van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW.

    Diabetes Care. 1998 Feb;21(2):278-82.PMID: 9539996 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Serum insulin and glucose concentrations in people at risk for type II diabetes. A comparative study of African Americans and Nigerians.

    Osei K, Cottrell DA, Adenuwon CA, Ezenwaka EC, Akanji AO, O'Dorisio TM.

    Diabetes Care. 1993 Oct;16(10):1367-75.PMID: 8269795 [PubMed - indexed for MEDLINE]Related articles

    10.

    Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

    Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC.

    Diabetes Care. 1998 May;21(5):810-6.PMID: 9589246 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.

    Røder ME, Schwartz RS, Prigeon RL, Kahn SE.

    J Clin Endocrinol Metab. 2000 Jun;85(6):2275-80.PMID: 10852463 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes.

    Osei K, Gaillard TR, Schuster DP.

    Diabetes Care. 1998 Aug;21(8):1250-7.PMID: 9702429 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Human aging is associated with parallel reductions in insulin and amylin release.

    Dechenes CJ, Verchere CB, Andrikopoulos S, Kahn SE.

    Am J Physiol. 1998 Nov;275(5 Pt 1):E785-91.PMID: 9814997 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

    Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE.

    Diabetes Care. 2007 Mar;30(3):677-82.PMID: 17327340 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Diabetes Care. 2004 Jun;27(6):1439-46.PMID: 15161801 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.

    Meier JJ, Nauck MA, Siepmann N, Greulich M, Holst JJ, Deacon CF, Schmidt WE, Gallwitz B.

    Metabolism. 2003 Dec;52(12):1579-85.PMID: 14669159 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus.

    Ezenwaka CE, Akanji AO, Osei K, Adejuwon CA, O'Dorisio TM, Cottrell DA, Akinlade KS.

    Diabetes Res Clin Pract. 1993 Jun;20(3):175-81.PMID: 8404450 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus]

    Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese. PMID: 17686259 [PubMed - indexed for MEDLINE]Related articles

    19.

    High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.

    Costa A, Rios M, Casamitjana R, Gomis R, Conget I.

    Diabetes Res Clin Pract. 1998 Sep;41(3):191-6.PMID: 9829348 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity